N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)ethyl]-3,4-dimethoxybenzamide

Catalog No. :
ACOJQK976
CAS No. :
1199216-01-7
Molecular Formula :
C13H16N4O3S
Molecular Weight :
308.36

IUPAC Name:N-(2-(5-amino-1,3,4-thiadiazol-2-yl)ethyl)-3,4-dimethoxybenzamide

N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)ethyl]-3,4-dimethoxybenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00Login to see priceInquiryInquiry
1g95%$388.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[2-(5-Amino-1,3,4-thiadiazol-2-yl)ethyl]-3,4-dimethoxybenzamide
IUPAC NameN-(2-(5-amino-1,3,4-thiadiazol-2-yl)ethyl)-3,4-dimethoxybenzamide
MDL No.MFCD13248739
Molecular FormulaC13H16N4O3S
Molecular Weight308.36
SMILESCOC1=C(OC)C=C(C=C1)C(=O)NCCC1=NN=C(N)S1
InChI KeyUTFWABGPSMLLSW-UHFFFAOYSA-N
Synonymbenzamide, N-[2-(5-amino-1,3,4-thiadiazol-2-yl)ethyl]-3,4-;N-[2-(5-amino-1,3,4-thiadiazol-2-yl)ethyl]-3,4-dimethoxybenzamide;Benzamide, N-[2-(5-amino-1,3,4-thiadiazol-2-yl)ethyl]-3,4-dimethoxy-
CAS No.1199216-01-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOJQK976 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSZQX153 route compound structure diagram
    ACSZQX1533535-37-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOJQK976 route product structure diagram
    ACOJQK9761199216-01-7
Inquiry

2. ACOJQK976 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTZEH710 route compound structure diagram
    ACTZEH71093-07-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOJQK976 route product structure diagram
    ACOJQK9761199216-01-7
Inquiry

Comments (0)